Design, Preparation, and Characterization of PNA-Based Hybridization Probes for Affibody-Molecule-Mediated Pretargeting

Bioconjugate Chemistry

Volumn 26, Issue 8, 2015, Pages 1724-1736

  Westerlund, Kristina ^a   Honarvar, Hadis ^b   Tolmachev, Vladimir ^b   Eriksson Karlström, Amelie ^a  

^a ALBANOVA UNIVERSITY CENTER   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BLOOD; CIRCULAR DICHROISM SPECTROSCOPY; DICHROISM; DISSOCIATION; NUCLEIC ACIDS; PROBES; RADIATION; RADIOACTIVITY; SURFACE PLASMON RESONANCE; SYNTHESIS (CHEMICAL); TUMORS;

AFFIBODY; AFFIBODY MOLECULES; BIODISTRIBUTIONS; DESIGN PREPARATION; HYBRIDIZATION PROBE; IN-VIVO; NORMAL TISSUE; PEPTIDE NUCLEIC ACID; RADIOIMMUNOTHERAPY; SURFACE-PLASMON RESONANCE;

AMINO ACIDS;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; INDIUM 111; IODINE 125; PEPTIDE NUCLEIC ACID; SORTASE; TETRAXETAN; TYROSINE; AFFIBODY (ZHER2-342)2; CHELATING AGENT; HYBRID PROTEIN; INDIUM; NUCLEIC ACID PROBE; RADIOACTIVE IODINE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CHIMERA; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; DISSOCIATION CONSTANT; HYBRIDIZATION; ISOTOPE LABELING; MELTING POINT; MOUSE; NONHUMAN; PLASMA CLEARANCE; PROTEIN SECONDARY STRUCTURE; RADIOACTIVITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE SYNTHESIS; SURFACE PLASMON RESONANCE; TRANSITION TEMPERATURE; ULTRAVIOLET RADIATION; ANIMAL; CHEMISTRY; DRUG DESIGN; FEMALE; IMMUNOLOGY; KIDNEY; METABOLISM; NUCLEIC ACID HYBRIDIZATION; NUCLEIC ACID PROBE; PHARMACOKINETICS; TISSUE DISTRIBUTION;

MUS;

ANIMALS; CHELATING AGENTS; DRUG DESIGN; FEMALE; INDIUM RADIOISOTOPES; IODINE RADIOISOTOPES; KIDNEY; MICE; NUCLEIC ACID HYBRIDIZATION; NUCLEIC ACID PROBES; PEPTIDE NUCLEIC ACIDS; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; SOLID-PHASE SYNTHESIS TECHNIQUES; SURFACE PLASMON RESONANCE; TISSUE DISTRIBUTION;

EID: 84939628085     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.5b00292     Document Type: Article

References (65)

1. Barbet, J., Bardiès, M., Bourgeois, M., Chatal, J. F., Chérel, M., Davodeau, F., Faivre-Chauvet, A., Gestin, J. F., and Kraeber-Bodéré, F. (2012) Radiolabeled antibodies for cancer imaging and therapy Methods Mol. Biol. 907, 681-697 10.1007/978-1-61779-974-7-38
2. Kraeber-Bodéré, F., Bodet-Milin, C., Rousseau, C., Eugène, T., Pallardy, A., Frampas, E., Carlier, T., Ferrer, L., Gaschet, J., and Davodeau, F. et al. 2014, Radioimmunoconjugates for the treatment of cancer Semin. Oncol. 41, 613-622 10.1053/j.seminoncol.2014.07.004
3. Wikman, M., Steffen, A. C., Gunneriusson, E., Tolmachev, V., Adams, G. P., Carlsson, J., and Ståhl, S. (2004) Selection and characterization of HER2/neu-binding affibody ligands Protein Eng., Des. Sel. 17, 455-462 10.1093/protein/gzh053
4. Orlova, A., Magnusson, M., Eriksson, T. L., Nilsson, M., Larsson, B., Höidén-Guthenberg, I., Widström, C., Carlsson, J., Tolmachev, V., Ståhl, S., and Nilsson, F. Y. (2006) Tumor imaging using a picomolar affinity HER2 binding affibody molecule Cancer Res. 66, 4339-4348 10.1158/0008-5472.CAN-05-3521
5. Friedman, M., Orlova, A., Johansson, E., Eriksson, T. L., Höidén-Guthenberg, I., Tolmachev, V., Nilsson, F. Y., and Ståhl, S. (2008) Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule J. Mol. Biol. 376, 1388-1402 10.1016/j.jmb.2007.12.060
6. Kronqvist, N., Malm, M., Göstring, L., Gunneriusson, E., Nilsson, M., Höidén-Guthenberg, I., Gedda, L., Frejd, F. Y., Ståhl, S., and Löfblom, J. (2011) Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules Protein Eng., Des. Sel. 24, 385-396 10.1093/protein/gzq118
7. Li, J., Lundberg, E., Vernet, E., Larsson, B., Höidén-Guthenberg, I., and Gräslund, T. (2010) Selection of affibody molecules to the ligand-binding site of the insulin-like growth factor-1 receptor Biotechnol. Appl. Biochem. 55, 99-109 10.1042/BA20090226
8. Honarvar, H., Garousi, J., Gunneriusson, E., Höidén-Guthenberg, I., Altai, M., Widström, C., Tolmachev, V., and Frejd, F. Y. (2014) Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX:1 affibody molecule Int. J. Oncol. 46, 513-520 10.3892/ijo.2014.2782
9. Feldwisch, J. and Tolmachev, V. (2012) Engineering of affibody molecules for therapy and diagnostics Methods Mol. Biol. 899, 103-126 10.1007/978-1-61779-921-1-7
10. Frampas, E., Rousseau, C., Bodet-Milin, C., Barbet, J., Chatal, J. F., and Kraeber-Bodéré, F. (2013) Improvement of radioimmunotherapy using pretargeting Front. Oncol. 3 00159 10.3389/fonc.2013.00159
11. Knight, J. C. and Cornelissen, B. (2014) Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy Am. J. Nucl. Med. Mol. Imaging 4, 96-113
12. van de Watering, F. C., Rijpkema, M., Robillard, M., Oyen, W. J., and Boerman, O. C. (2014) Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry Front. Med. 1 00044 10.3389/fmed.2014.00044
13. Hnatowich, D. J., Virzi, F., and Rusckowski, M. (1987) Investigations of avidin and biotin for imaging applications J. Nucl. Med. 28, 1294-1302
14. Liu, G. and Hnatowich, D. J. (2008) A semiempirical model of tumor pretargeting Bioconjugate Chem. 19, 2095-2104 10.1021/bc8002748
15. Knox, S. J., Goris, M. L., Tempero, M., Weiden, P. L., Gentner, L., Breitz, H., Adams, G. P., Axworthy, D., Gaffigan, S., and Bryan, K. et al. 2000, Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer Clin. Cancer Res. 6, 406-414
16. Rusckowski, M., Fogarasi, M., Virzi, F., and Hnatowich, D. J. (1995) Influence of endogenous biotin on the biodistribution of labelled biotin derivatives in mice Nucl. Med. Commun. 16, 38-46 10.1097/00006231-199501000-00009
17. Rosebrough, S. F. (1993) Plasma stability and pharmacokinetics of radiolabeled deferoxamine-biotin derivatives J. Pharmacol. Exp. Ther. 265, 408-415
18. Reardan, D. T., Meares, C. F., Goodwin, D. A., McTigue, M., David, G. S., Stone, M. R., Leung, J. P., Bartholomew, R. M., and Frincke, J. M. (1985) Antibodies against metal chelates Nature 316, 265-268 10.1038/316265a0
19. Gautherot, E., Bouhou, J., Le Doussal, J. M., Manetti, C., Martin, M., Rouvier, E., and Barbet, J. (1997) Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten Cancer 80, 2618-2623 10.1002/(SICI)1097-0142(19971215)80:12+<2618::AID-CNCR37>3.0.CO;2-D
20. Rossin, R., Renart Verkerk, P., van den Bosch, S. M., Vulders, R. C., Verel, I., Lub, J., and Robillard, M. S. (2010) In vivo chemistry for pretargeted tumor imaging in live mice Angew. Chem., Int. Ed. 49, 3375-3378 10.1002/anie.200906294
21. Devaraj, N. K., Thurber, G. M., Keliher, E. J., Marinelli, B., and Weissleder, R. (2012) Reactive polymer enables efficient in vivo bioorthogonal chemistry Proc. Natl. Acad. Sci. U.S.A. 109, 4762-4767 10.1073/pnas.1113466109
22. Zeglis, B. M., Sevak, K. K., Reiner, T., Mohindra, P., Carlin, S. D., Zanzonico, P., Weissleder, R., and Lewis, J. S. (2013) A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry J. Nucl. Med. 54, 1389-1396 10.2967/jnumed.112.115840
23. Rossin, R., van den Bosch, S. M., Ten Hoeve, W., Carvelli, M., Versteegen, R. M., Lub, J., and Robillard, M. S. (2013) Highly reactive trans-cyclooctene tags with improved stability for Diels-Alder chemistry in living systems Bioconjugate Chem. 24, 1210-1217 10.1021/bc400153y
24. Rossin, R., van Duijnhoven, S. M., Läppchen, T., van den Bosch, S. M., and Robillard, M. S. (2014) Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction Mol. Pharmaceutics 11, 3090-3096 10.1021/mp500275a
25. Liu, G., Mangera, K., Liu, N., Gupta, S., Rusckowski, M., and Hnatowich, D. J. (2002) Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog J. Nucl. Med. 43, 384-391
26. Liu, G., Dou, S., Baker, S., Akalin, A., Cheng, D., Chen, L., Rusckowski, M., and Hnatowich, D. J. (2010) A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49 Cancer Biol. Ther. 10, 767-774 10.4161/cbt.10.8.12879
27. Liu, G., Dou, S., Liu, Y., Wang, Y., Rusckowski, M., and Hnatowich, D. J. (2011) 90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy Bioconjugate Chem. 22, 2539-2545 10.1021/bc200366t
28. Nielsen, P. E., Egholm, M., and Buchardt, O. (1994) Peptide nucleic acid (PNA). A DNA mimic with a peptide backbone Bioconjugate Chem. 5, 3-7 10.1021/bc00025a001
29. Nielsen, P. E. (1999) Peptide nucleic acid. A molecule with two identities Acc. Chem. Res. 32, 624-630 10.1021/ar980010t
30. Egholm, M., Buchardt, O., Christensen, L., Behrens, C., Freier, S. M., Driver, D. A., Berg, R. H., Kim, S. K., Norden, B., and Nielsen, P. E. (1993) PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules Nature 365, 566-568 10.1038/365566a0
31. Demidov, V. V., Potaman, V. N., Frank-Kamenetskii, M. D., Egholm, M., Buchard, O., Sönnichsen, S. H., and Nielsen, P. E. (1994) Stability of peptide nucleic acids in human serum and cellular extracts Biochem. Pharmacol. 48, 1310-1313 10.1016/0006-2952(94)90171-6
32. Cutrona, G., Boffa, L. C., Mariani, M. R., Matis, S., Damonte, G., Millo, E., Roncella, S., and Ferrarini, M. (2007) The peptide nucleic acid targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitts lymphoma lacks immunogenicity: follow-up characterization of PNAEμ-NLS Oligonucleotides 17, 146-150 10.1089/oli.2007.9999
33. Upadhyay, A., Ponzio, N. M., and Pandey, V. N. (2008) Immunological Response to Peptide Nucleic Acid and its Peptide Conjugate Targeted to Transactivation Response (TAR) Region of HIV-1 RNA Genome Oligonucleotides 18, 329-335 10.1089/oli.2008.0152
34. Ray, A. and Nordén, B. (2000) Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future FASEB J. 14, 1041-1060
35. Mardirossian, G., Lei, K., Rusckowski, M., Chang, F., Qu, T., Egholm, M., and Hnatowich, D. J. (1997) In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA) J. Nucl. Med. 28, 907-913
36. McMahon, B. M., Mays, D., Lipsky, J., Stewart, J. A., Fauq, A., and Richelson, E. (2002) Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration Antisense Nucleic Acid Drug Dev. 12, 65-70 10.1089/108729002760070803
37. Rusckowski, M., Qu, T., Chang, F., and Hnatowich, D. J. (1997) Pretargeting using peptide nucleic acid Cancer 80, 2699-2705 10.1002/(SICI)1097-0142(19971215)80:12+<2699::AID-CNCR48>3.3.CO;2-A
38. Totsingan, F., Jain, V., Bracken, W. C., Faccini, A., Tedeschi, T., Marchelli, R., Corradini, R., Kallenbach, N. R., and Green, M. M. (2010) Conformational Heterogeneity in PNA:PNA Duplexes Macromolecules 43, 2692-2703 10.1021/ma902797f
39. Armitage, B., Ly, D., Koch, T., Frydenlund, H., Ørum, H., and Schuster, G. B. (1998) Hairpin-forming peptide nucleic acid oligomers Biochemistry 37, 9417-9425 10.1021/bi9729458
40. Armitage, B. A. (2003) The impact of nucleic acid secondary structure on PNA hybridization Drug Discovery Today 8, 222-228 10.1016/S1359-6446(03)02611-4
41. Hunter, W. M. and Greenwood, F. C. (1962) Preparation of iodine-131 labelled human growth hormones of high specific activity Nature 194, 495-496 10.1038/194495a0
42. Wilbur, D. S. (1992) Radiohalogenation of proteins: an overview of radionuclides, labeling methods, and reagents for conjugate labeling Bioconjugate Chem. 3, 433-470 10.1021/bc00018a001
43. Nielsen, P. E. and Egholm, M. (1999) An Introduction to Peptide Nucleic Acid Curr. Issues Mol. Biol. 1, 89-104
44. Nielsen, P. E., Haaima, G., Lohse, A., and Buchardt, O. (1996) Peptide Nucleic Acids (PNA) containing thymine monomers derived from chiral amino acids: Hybridization and solubility properties of d -lysine PNA Angew. Chem., Int. Ed. Engl. 35, 1939-1942 10.1002/anie.199619391
45. Wållberg, H., Orlova, A., Altai, M., Hosseinimehr, S. J., Widström, C., Malmberg, J., Ståhl, S., and Tolmachev, V. (2011) Molecular design and optimization of 99mTc-labeled recombinant affibody molecules improves their biodistribution and imaging properties J. Nucl. Med. 52, 461-469 10.2967/jnumed.110.083592
46. de Koning, M. C., van der Marel, G. A., and Overhand, M. (2003) Synthetic developments towards PNA-peptide conjugates Curr. Opin. Chem. Biol. 7, 734-740 10.1016/j.cbpa.2003.10.006
47. McCluskey, A. J. and Collier, R. J. (2013) Receptor-directed chimeric toxins created by sortase-mediated protein fusion Mol. Cancer Ther. 12, 2273-2281 10.1158/1535-7163.MCT-13-0358
48. Leung, M. K., Hagemeyer, C. E., Johnston, A. P., Gonzales, C., Kamphuis, M. M., Ardipradja, K., Such, G. K., Peter, K., and Caruso, F. (2012) Bio-click chemistry: enzymatic functionalization of PEGylated capsules for targeting applications Angew. Chem., Int. Ed. 51, 7132-7136 10.1002/anie.201203612
49. Löfblom, J., Feldwisch, J., Tolmachev, V., Carlsson, J., Ståhl, S., and Frejd, F. Y. (2010) Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications FEBS Lett. 584, 2670-2680 10.1016/j.febslet.2010.04.014
50. Mazmanian, S. K., Liu, G., Ton-That, H., and Schneewind, O. (1999) Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall Science 285, 760-763 10.1126/science.285.5428.760
51. Popp, M. W. and Ploegh, H. L. (2011) Making and breaking peptide bonds: protein engineering using sortase Angew. Chem., Int. Ed. 50, 5024-5032 10.1002/anie.201008267
52. Ritzefeld, M. (2014) Sortagging: a robust and efficient chemoenzymatic ligation strategy Chem.-Eur. J. 20, 8516-8529 10.1002/chem.201402072
53. Warden-Rothman, R., Caturegli, I., Popik, W., and Tsourkas, A. (2013) Sortase-tag expressed protein ligation: Combing protein purification and site-specific bioconjugation into a single step Anal. Chem. 85, 11090-11097 10.1021/ac402871k
54. Pritz, S., Wolf, Y., Kraetke, O., Klose, J., Bienert, M., and Beyermann, M. (2007) Synthesis of biologically active peptide nucleic acid-peptide conjugates by sortase-mediated ligation J. Org. Chem. 72, 3909-3912 10.1021/jo062331l
55. Corradini, R., Tedeschi, T., Sforza, S., and Marchelli, R. (2012) Electronic circular dichroism of peptide nucleic acids and their analogues. In Comprehensive Chiroptical Spectroscopy: Applications in Stereochemical Analysis of Synthetic Compounds, Natural Products, and Biomolecules (Berova, N., Polavarapu, P. L., Nakanishi, K., and Woody, R. W., Eds.), Vol. 2, Chapter 18, John Wiley & Sons, Inc., Hoboken, NJ.
56. Chen, S., Mohan, V., Kiely, J. S., Griffith, M. C., and Griffey, R. H. (1994) Molecular dynamics and NMR studies of single-stranded PNAs Tetrahedron Lett. 35, 5105-5108 10.1016/S0040-4039(00)77039-0
57. He, J., Liu, G., Zhang, S., Vanderheyden, J. L., Liu, N., Liu, C., Zhang, Y., Gupta, S., Rusckowski, M., and Hnatowich, D. J. (2003) A comparison of in vitro and in vivo stability in mice of two morpholino duplexes differing in chain length Bioconjugate Chem. 14, 1018-1023 10.1021/bc0341019
58. Wang, Y., Chang, F., Zhang, Y., Liu, N., Liu, G., Gupta, S., Rusckowski, M., and Hnatowich, D. J. (2001) Pretargeting with amplification using polymeric peptide nucleic acid Bioconjugate Chem. 12, 807-816 10.1021/bc0100307
59. Wållberg, H., Löfdahl, P.-A., Tschapalda, K., Uhlén, M., Tolmachev, V., Nygren, P.-A., and Ståhl, S. (2011) Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand Protein Expression Purif. 76, 127-135 10.1016/j.pep.2010.10.008
60. Ekblad, T., Tolmachev, V., Orlova, A., Lendel, C., Abrahmsén, L., and Karlström, A. E. (2009) Synthesis and chemoselective intramolecular crosslinking of a HER2-binding affibody Biopolymers 92, 116-123 10.1002/bip.21142
61. Orlova, A., Tran, T., Widström, C., Engfeldt, T., Eriksson Karlström, A., and Tolmachev, V. (2007) Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors Int. J. Mol. Med. 20, 397-404 10.3892/ijmm.20.3.397
62. Honovar, H., Westerlund, K., Altai, M., Sandström, M., Orlova, A., Tolmachev, V., and Eriksson Karlström, A. (2015) Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting, unpublished results.
63. Kobashigawa, Y., Kumeta, H., Ogura, K., and Inagaki, F. (2009) Attachment of an NMR-invisible solubility enhancement tag using a sortase-mediated protein ligation method J. Biomol. NMR 43, 145-150 10.1007/s10858-008-9296-5
64. Wållberg, H., Grafström, J., Cheng, Q., Lu, L., Martinsson Ahlzén, H. S., Samén, E., Thorell, J. O., Johansson, K., Dunås, F., and Olofsson, M. H. et al. 2012, HER2-positive tumors imaged within 1 h using a site-specifically 11C-labeled Sel-tagged affibody molecule J. Nucl. Med. 53, 1446-1453 10.2967/jnumed.111.102194
65. Schmid, F. (2001) Biological Macromolecules: UV-visible Spectrophotometry. In eLS, Wiley: Chichester, U.K., http://www.els.net, DOI: 10.1038/npg.els.0003142.